NCT00537680 - Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

Friedreich's Ataxia

Interventions

DRUG

Idebenone

Patients ≤ 45 kg/99 lbs: idebenone 450 mg/day; Patients \> 45 kg/99 lbs: idebenone 900 mg/day

DRUG

Idebenone

Patients ≤ 45 kg/99 lbs: idebenone 1350 mg/day; Patients \> 45 kg/99 lbs: idebenone 2250 mg/day

DRUG

Placebo

Placebo was provided as film-coated tablets that were the same size, weight and appearance as the idebenone tablets.

Trial Locations (2)

The Children's Hopsital of Philadelphia, Philadelphia

David Geffen School of Medicine, UCLA, Los Angeles